C-EQFTPrellis Biologics
AI antibody discovery, bioprinted organoids, immune diversity
discoverydiscoveringbiologic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-EQFT
C-EQFTC-EQFTAI antibody discovery, bioprinted organoids, immune diversity
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Prellis Biologics states that it is creating engineered human tissues and organs using a proprietary laser-based 3D printing technology, reflecting a belief that combining engineering and biology can solve unmet medical needs.
SourcePrellis Biologics states that lab-grown human organs and tissues are achievable and that its holographic bioprinting technology can help make them possible by rapidly building complex, transplant-compatible 3D tissue structures and addressing what it describes as the final roadblock in creating lab-grown human tissues.
SourcePrellis Biologics states that it is building a platform to create human tissues de novo by combining advances in cellular biology with laser-based photolithography. The company presents a multidisciplinary view of tissue engineering grounded in understanding cell-cell interactions, developmental signaling, and tissue microenvironments, with the goal of applying these capabilities to pharmaceutical research, space medicine, and tissue transplantation.
Source